Motavizumab Administration for a Second Season for RSV Prophylaxis
1 clinical trials · Condition
◉ Watch Motavizumab Administration for a Second Season for RSV Prophylaxis
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Motavizumab (MEDI-524) After Dosing for a Second Season in Children (NCT00113490) | MedImmune LLC | 2005-05-01 |
Track Motavizumab Administration for a Second Season for RSV Prophylaxis automatically
Every clearance here is in the API, with alerts when new ones post.